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ABSTRACT
Introduction: Early identification (EI) and brief
interventions (BIs) for risky drinkers are effective tools
in primary care. Lack of time in daily practice has been
identified as one of the main barriers to implementation
of BI. There is growing evidence that facilitated access
by primary healthcare professionals (PHCPs) to a web-
based BI can be a time-saving alternative to standard
face-to-face BIs, but there is as yet no evidence about
the effectiveness of this approach relative to
conventional BI. The main aim of this study is to test
non-inferiority of facilitation to a web-based BI for risky
drinkers delivered by PHCP against face-to-face BI.
Method and analysis: A randomised controlled non-
inferiority trial comparing both interventions will be
performed in primary care health centres in Catalonia,
Spain. Unselected adult patients attending participating
centres will be given a leaflet inviting them to log on to
a website to complete the Alcohol Use Disorders
Identification Test (AUDIT-C) alcohol screening
questionnaire. Participants with positive results will be
requested online to complete a trial module including
consent, baseline assessment and randomisation to
either face-to-face BI by the practitioner or BI via the
alcohol reduction website. Follow-up assessment of
risky drinking will be undertaken online at 3 months and
1 year using the full AUDIT and D5-EQD5 scale.
Proportions of risky drinkers in each group will be
calculated and non-inferiority assessed against a
specified margin of 10%. Assuming reduction of 30%
of risky drinkers receiving standard intervention, 1000
patients will be required to give 90% power to reject the
null hypothesis.
Ethics and dissemination: The protocol was
approved by the Ethics Commmittee of IDIAP Jordi Gol i
Gurina P14/028. The findings of the trial will be
disseminated through peer-reviewed journals, national
and international conference presentations.
Trial registration number: ClinicalTrials.gov
NCT02082990.
INTRODUCTION
Risky drinking is a worldwide public health
problem. In total, 74% of Europeans aged
15 years or older drink alcohol and 15% of
them (58 million people) drink above the
recommended level.1 Around the world,
3.8% of premature deaths and 4.6% of
disability-adjusted life years (DALYs) lost are
attributable to alcohol use.2
In Catalonia, one of ﬁve patients attending
primary healthcare are risky drinkers.3
However, the proportion of people who access
treatment out of those who need it varies from
4% (Germany) to 23% (Italy). In Spain, the
percentage of the in-need population-accessing
treatment is 15.3%.4 5
Early identiﬁcation (EI) and brief interven-
tion (BI) are among the most effective
approaches for risky drinkers in primary
healthcare.6 7 However, there is an important
gap between research and clinical practice.8
Less than 10% of risky drinkers attended the
primary healthcare beneﬁt from BI.7 The
main barriers in implementing EI and BI in
primary care are time constraints, lack of
ﬁnancial incentives, insufﬁcient training or
absence of services to refer patient to and risk
of upsetting patient.4 Web-based BIs (e-BIs)
are an alternative to improve the implementa-
tion, acceptance and viability of BI and to
overcome barriers that have hampered their
use in daily practice.9 10 The provision of
facilitated access by primary care profes-
sionals to an alcohol reduction website could
signiﬁcantly increase BI rates by offering a
time-saving alternative to face-to-face inter-
vention. Many studies have shown the efﬁcacy
of computer-based interventions in getting
college students to reduce their alcohol con-
sumption.11 12 The use of new technologies
for mental health problems is becoming
common in primary care, as, for example, in
smoking cessation.13 A review of trials of
computer-based interventions in college drin-
kers found them to be more effective than no
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treatment and as effective as alternative treatment
approaches.11
Down Your Drink (DYD; http://www.downyourdrink.
org.uk) is an online intervention developed in UK based
on BI, cognitive–behavioural therapy, self-control therapy
and motivational interviewing. An online trial of DYD
indicated potentially signiﬁcant reductions in alcohol
consumption and risky drinking behaviours in partici-
pants who used the trial websites,14 and, following this, a
number of initiatives have been initiated to test the
acceptability and effectiveness of facilitating access to
websites of this kind in primary care settings. The
EU-funded ODHIN trial15 currently underway in ﬁve
European countries is designed to determine the impact
of facilitated access on levels of implementation of BIs by
primary care practitioners. The EFAR FVG study in the
Friuli Venezia Giulia region in Northern Italy16 has been
designed to test the effectiveness relative to face-to-face
intervention of facilitated access to an Italian version of
DYD by general practitioners. This trial involves 40
general practices and has recruited more than 500
patients.16 EFAR-Spain is based on the EFAR-FVG study,
but has the following differences: (1) participation is
open to doctors as well as nurses; (2) primary healthcare
centres are constituted by a team of different profes-
sionals (nursing, medicine, social work, administration,
etc); and (3) the website has not only been translated but
also adapted to Spanish culture.
In Catalonia, no efﬁcacy studies on e-BI exist.
However, some limited e-BI initiatives have been under-
taken in order to support the implementation of the
‘Beveu Menys’ programme,17 a programme aimed at
implementing EI and BI by, among other strategies,
identifying a Network of Alcohol Referents in Primary
Health Care (XaROH) throughout the territory and
providing continuous training and support to them. An
online quantity–frequency tool was developed and pro-
moted to be used as a general population awareness-
raising tool with promising results.18 Recently, in the
context of the ODHIN project,19 an e-BI tool, adapted
from Drinkers Check-Up,20 was used to test facilitated
access only, but results are still under analysis.
We present the protocol of a randomised controlled
non-inferiority trial (1:1) which aims to test non-inferiority
of an e-BI for risky drinkers against a traditional
face-to-face BI delivered by a primary healthcare profes-
sional (PHCP; nurse or general practitioners (GPs)).
METHOD
Trial design: A randomised non-inferiority controlled trial
in primary care comparing facilitated access to a website
for risky drinkers against a standard face-to-face BI. With
the exception of the non-experimental intervention, all
components of the study will be administered online to
patients. Patients will be actively encouraged by their
PHCP to access the application, which is available on
the website of the programme ‘Alcohol y Salud’ (http://
www.alcoholysalud.cat), and will be provided with a
unique registration code.
The trial website is a Spanish adaptation of the English
version of http://www.DownYourDrink.org.uk (DYD)
developed in the UK, which includes modules for all the
key trial components including screening, consent,
assessment, randomisation and follow-up. It also incor-
porates the alcohol reduction website for the patients in
the experimental group. The site has been adapted
from the http://www.DownYourDrink.org.uk website
developed for the DYD-RCT (randomised controlled
trial).14 Details of DYD and the psychological theory that
underpinned its development have been reported else-
where.21 Country-speciﬁc information such as recom-
mended guidelines for alcohol intake, deﬁnitions of
standard drinks and alcohol-related laws will be
included. The website also incorporates a menu-driven
facility to enable PHCP to customise automated mes-
sages to patients, for example, by adding photographs
and pre-recorded messages. The personalised messages
will appear to each patient using the log-in code pro-
vided by that practitioner.
Practitioner recruitment, training and incentives:
Recruitment will be based on the XaROH network.
A 3 h seminar on new technologies, and EI and BI,
introducing the trial, will be offered to all members of
the XaROH, and those attending will be invited to sign
up for the trial. In addition, several advertisements will
be posted on the ‘Beveu Menys’ platform offering par-
ticipation in the trial. In selecting practices, preference
will be given to those with at least 5000 registered
patients. Those practices that are selected as participants
will be required to undergo a 1-day training programme.
The training has four steps: (1) introduction to trial;
(2) familiarisation with website; (3) update about EI and
BI; and (4) practice in EI and BI (role-playing). Finally,
participants will be encouraged to use the website and
to tailor-make patient messages. Participating PHCPs will
receive a ﬁnancial incentive of €20 per patient recruited
to the trial.
Patient eligibility
Inclusion criteria: patients aged 18 years or older attend-
ing the participating practices during the study period.
Exclusion criteria: those suffering from severe psychi-
atric disorders, serious visual impairment or terminal
illness, those having inadequate command of the
Spanish or Catalan language, or Alcohol Use Disorders
Identiﬁcation Test (AUDIT) ≥18 in baseline assessment.
Excluded patients will be referred to PHCP to consider
other interventions.
Screening and Consent: Eligible patients will be given a
trial brochure by their GP or nurse and actively encour-
aged to access the specially designed website ‘http://
www.alcoholysalud.cat’. Each brochure will include a
unique access number that will enable the patient to log
on to the website. All patients who access the website will
be informed about the trial and asked to complete an
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online form conﬁrming that they do not meet any of
the exclusion criteria and inviting them to complete the
online consent module. They will then be asked to com-
plete an online version of the short AUDIT-C.22 Cut-off
points for the purpose of the trial will be 4 for women
and 5 for men. Those screening negative will be
informed that their responses indicated acceptable
drinking patterns according to national guidelines and
will be encouraged not to increase their alcohol con-
sumption. Those scoring at or above the cut-off point
will be invited by tailored online message from their
PHCP to take part in the study as they present a risky
drinking pattern (ﬁgure 1).
Baseline assessment includes a demographic question-
naire (age, gender, level of education and occupation),
the 10-question Alcohol Use Disorder Test Spanish
version23 and D5-EQ D5, the quality-of-life question-
naire, validated in Spanish versions.24 25
Randomisation and intervention: Those patients who com-
plete the baseline assessment will undergo automated
online randomisation by a speciﬁc module of website
(1:1). Experimental group patients will be taken direct to
the registration page of the alcohol reduction website
‘Alcohol y Salud’ (http://www.alcoholysalud.cat), where
they will receive a personalised message from the PHCP
who gave them the brochure with tailored feedback about
their responses to the alcohol questionnaires. Personalised
online messages from their PHCP will inform the patients
of the importance of adopting healthy drinking choices
and will encourage them to spend at least 15 min
engaging with the alcohol reduction website in the ﬁrst
instance. Each participating PHCP will have access to the
section of website enabling them to personalise their mes-
sages (see ‘Trial website’). Patients will also receive an
email 1 week later encouraging them to log on again to
review their alcohol consumption. Online messages will
also encourage the patients to discuss their website experi-
ence when they next see their PHCP.
Control group patients will receive an online message
asking them to make an appointment to see their PHCP
to discuss their drinking, and an automatically generated
email will also be sent to their PHCP to set up a visit in
the next 7–10 days. At the appointment, the patient will
receive a face-to-face brief motivational interview with
the following components: (1) assessment of the motiv-
ation to change; (2) assessment of the stage of change;
(3) advice on changing drinking pattern; (4) empathy;
and (5) capacity building.
Non-attenders will be offered up to three additional
recalls.
Figure 1 Flow chart: recruitment
process (PHCP, primary
healthcare professional;
AUDIT-C, Alcohol Use Disorders
Identification Test).
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Follow-up assessment
Follow-up will take place at 3 and 12 months after ran-
domisation, and each assessment will consist of the fol-
lowing instruments:
1. The 10-question AUDIT validated Spanish version.
2. The EQ-5D-5 self-complete Spanish version (http://
www.euroqol.org/eq-5d-products/eq-5d-5l.html)
Up to three attempts by email will be made to ensure
follow-up. The last attempt will be made by the PHCP by
letter, phone or in person. There are no restrictions to
concomitant care.
Data security and storage
In order to ensure the security of personal data of partici-
pating patients and healthcare professionals, the site will
be hosted on its own separate server, which will be main-
tained and monitored closely throughout the project.
All communication between participants or PHCP and
the web server will take place over an encrypted ‘http’
connection.
Similarly, any interaction with the web server by
research staff or technical maintenance staff will be over
a secure connection.
Access to the website and web server will be restricted
to a small number of research and technical staff. The
data will be collected and stored in accordance with best
practices. All outcome data will be anonymised and
identiﬁable only by a patient’s unique ID and code.
Access to the ﬁnal trial data set will be limited to the
research team.
Statistical analysis
The primary outcome will be the proportion of patients
classiﬁed as risky drinkers by the AUDIT-10 at month 3
after the randomisation.
Aiming to assess the non-inferiority of facilitated access
compared with standard face-to-face intervention, the
proportion of risky drinkers in both groups will be com-
pared using generalised non-linear mixed models. Non-
inferiority will be considered if the difference between
groups is not greater than 10%. Based on an anticipated
reduction of 30% in the proportion of risky drinkers in
control group and an overall attrition of 10%, it is calcu-
lated that 500 patients in each group will be needed to
reject the null hypothesis (facilitated access is inferior to
standard face-to-face intervention) with 90% power.
No interim analysis is planned.
All analysis details will be set up in a predesignated
statistical analysis plan before the data are accessed.
Impact on screening rates of facilitated access
to the website
It is hypothesised that the provision of facilitated access
to the website will lead to an increase in alcohol screen-
ing rates in the trial practices. A substudy will therefore
be carried out comparing pre-trial and post-trial alcohol
screening rates in the participating practices, calculated
on the basis of entries in the electronic care records of
patients attending over a 6-month period. Further com-
parison will be carried out with a matched control group
of practices that did not participate in the EFAR trial.
DISCUSSION
The trial has several strengths. The research team
includes international expertise and the protocol
beneﬁts from extensive experience gained through
the EFAR FVG trial, which has recruited well and
achieved high rates of follow-up. Recruitment of PHCPs
will be achieved using an established, structured and
well-trained network that has been involved in previous
alcohol projects including ODHIN, PHEPA and Beveu
Menys. The trainers have also had extensive experience
of SBI training, and the network includes nursing as
well as medical professionals, thus offering the potential
to recruit a wide range of patients. It is the ﬁrst trial
testing the utility of facilitated access in Spain. It is
carried out in the context of the daily work of PHCPs
and can be embedded in the alcohol SBI activities
undertaken in Catalonia so far. It is a natural evolution
of the work being done and if results are positive such a
website could be included in the future in the personal
ﬁle of PHCPs and promoted as a complementary tool
throughout all primary healthcare centres.
There may be initial professional resistance to
engaging with facilitated access activity as the trial will be
carried out by PHCPs with little or no experience of pro-
moting the use of the internet for the delivery of
alcohol screening and BI. However, we have taken
account of this by using conservative estimates in calcu-
lating the anticipated facilitated access rates, and will
offer training to all the participating PHCPs in order to
overcome usability problems. The current version of the
website has been well-accepted by Italian professionals
and patients,26 and all the professionals participating in
the EFAR Spain trial will be invited to familiarise them-
selves with the website prior to the start of the trial.
Furthermore, the research team will provide continuous
support though email, an internet forum and by tele-
phone. Support materials will also be provided, includ-
ing Frequently Asked Questions (FAQs), feedback data
and alcohol-related problems management documents.
It is likely that a degree of selection bias will result from
increased participation by younger and better educated
patients likely to be more familiar with the internet.
However, baseline assessment will provide data on a range
of demographics, enabling comparisons to be made with
the general population. While it is also possible that the
trial will select more motivated participants who are espe-
cially concerned about their alcohol use, randomisation
should ensure that these effects are equally distributed
between the intervention and control groups.
In conclusion, while the trial poses signiﬁcant chal-
lenges, it also has the beneﬁt of international experience
and expertise and delivery by PHCPs from a structured
network with extensive previous experience.
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